MemScreen

We were honored to present MemScreen, our smartphone-based cognitive screening tool, at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2025) held in Vienna, Austria, from April 1–5, 2025. MemScreen was featured as an oral communication, highlighting its clinical rationale, digital interface, and scientific validation in both general population cohorts and memory clinic settings. 📸 Presentation snapshot Pr. Julien Dumurgier presenting MemScreen at AD/PD 2025 – Vienna 📄 Download the PDF 🗂️ You can download the full slide deck of the oral communication via the link below: 👉 Download the AD/PD 2025 presentation (PDF) 🧪 About MemScreen MemScreen is a quick cognitive screening app designed to help healthcare providers identify mild cognitive impairment (MCI) in under 5 minutes. The app includes: Pre-test info: age, sex, education level Part 1: Verbal memory encoding (12 words) Part 2: Intermediate tasks (orientation, arithmetic, distractor dete...

🧠 MemScreen: A Scientifically Validated App for Early Cognitive Screening We are proud to announce that our research on MemScreen , a smartphone-based cognitive screening tool, has been published in the journal The Journal of Prevention of Alzheimer’s Disease : 🔗 Read the full article on ScienceDirect 📱 What is MemScreen? MemScreen is a smartphone application designed to screen for mild cognitive impairment (MCI) , a condition often preceding Alzheimer’s disease. The app offers a quick, self-administered test assessing both global cognition and verbal memory, under the supervision of a healthcare provider. It’s available for both Android and iOS devices and can be integrated into routine clinical practice. 🔬 What Did the Study Show? Our study validated MemScreen in two populations: General population (UK - Whitehall II Study): In over 2,000 older adults, MemScreen outperformed traditional tools like the MMSE and TMT-A with an AUC of 0.87 , and balanced sensitivit...